Clinical Trials Logo

Clinical Trial Summary

Introduction:

Cardiovascular diseases have become the leading cause of death from chronic diseases in the world. One of the major risk factors for this disease is hypercholesterolemia, caused in most cases by a rich-fat diet, so came to our country Benecol ® yogurt, whose active ingredient is plant stanol ester that competes with total cholesterol and low density lipoprotein or LDL cholesterol by preventing them to be absorbed by the body and reducing blood levels.

Objective: To evaluate the efficacy of plant stanol ester in Benecol ® yogurt lowering blood lipids in moderately hypercholesterolemic patients treated at the CES Clinic during 2011.

Methods: A randomized crossover clinical trial, double-blind, placebo-controlled study in patients between 20 and 50 years with moderate hypercholesterolemia and are cared for CES control clinic in Medellin.

Expected results: Test the effectiveness of plant stanol esters in reducing total cholesterol and LDL cholesterol in patients with moderate hypercholesterolemia.


Clinical Trial Description

The main cause of death worldwide are cardiovascular diseases, generated mainly by disturbances in the lipid profile. Several studies have shown that dyslipidemia is an important risk factor for this condition, thus maintaining the level of lipids in an appropriate range is ideal for preventing cardiovascular diseases (1)

Cardiovascular diseases are a serious epidemiological problem in the contemporary world, with approximately 17 million people die each year from causes such as myocardial infarction and stroke. The increase in cardiovascular disease and mortality attributable to them is a topic widely reported by several authors in the world. In Colombia after death from violent causes, cardiovascular diseases are on the second of the five leading causes of mortality in the general population.

Having high total cholesterol is a risk factor for the occurrence of various diseases of the circulatory system, therefore it is important to keep total cholesterol below 200 mg / dl and LDL cholesterol levels under 150 mg/dl, to avoid the accumulation of fat within the walls of the arteries that can lead to the formation of atherosclerotic plaques that cause decreased blood flow

The atlas published by WHO in 2005 provides comprehensive data on morbidity and mortality attributable to noncommunicable diseases, which are increasing. It is estimated that in 2001 approximately 60% of the 56.5 million deaths worldwide and 46% of diseases are due to noncommunicable diseases. The epidemiological burden of these diseases will increase to 57% by the year 2020. Almost 50% of deaths due to noncommunicable diseases are due to cardiovascular disease. By 2020, these diseases are responsible for 75% of all deaths worldwide.

Given the high prevalence of cardiovascular disease and dyslipidemia are considered a high risk factor for these occur, it is necessary to test the effectiveness of including the consumption of plant stanol esters in the diet to lower cholesterol values Total and LDL Cholesterol. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01461798
Study type Interventional
Source CES University
Contact Johanna Romero Palacio, Microbiologa
Phone 300788362
Email jrp922@gmail.com
Status Not yet recruiting
Phase N/A
Start date October 2011
Completion date March 2012

See also
  Status Clinical Trial Phase
Completed NCT02007681 - What is in Fact the Contribution of Reducing Time Spent in Sedentary Behaviors on Daily Energy Expenditure? A Doubly Labeled Water Study N/A
Completed NCT01395095 - OPTImal CArdiac REhabilitation (OPTICARE) Following Acute Coronary Syndromes N/A
Active, not recruiting NCT00443586 - Follow-up Evaluation of Home Nurse Visitation Program for Socially Disadvantaged Women and Their Children N/A
Completed NCT00438165 - Age 12 Follow-up of Early Preventive Intervention (Memphis) N/A
Completed NCT04164277 - FirstStep2Health Intervention N/A
Completed NCT04526873 - Encouraging Annual Wellness Visits Among ACO Beneficiaries N/A
Completed NCT03196024 - Corazon de la Familia (Heart of the Family) N/A
Completed NCT03287622 - Evaluation of an Interactive Opioid Risk Education Program (STOMP) for Parents N/A
Withdrawn NCT01169922 - HIV Prevention With Adolescents: Neurocognitive Deficits and Treatment Response N/A
Completed NCT04853394 - Tajik Migrant Health Education Study N/A
Completed NCT01291589 - HIV Prevention in Very High Risk Men Who Have Sex With Men Phase 1
Completed NCT02311400 - Self-Affirmation, Emotion, and Alcohol Consumption
Completed NCT03863353 - Scenario Tailored Opioid Messaging Program (STOMP) to Improve Risk Understanding in Young Adults N/A
Not yet recruiting NCT05732714 - Long Term Cardiovascular Disease Event Risk for Patients Undergoing Major Non-Cardiac Surgery
Not yet recruiting NCT02648555 - A Lifestyle Intervention to Improve in Vitro Fertilization Results N/A
Completed NCT00443638 - Longitudinal Follow Up of Subjects Enrolled in Randomized Trial of Prenatal and Infancy Home Visitation N/A
Completed NCT00906321 - Facilitating Web-based Patient Decision Support: Decision About Medication to Lower Breast Cancer Risk N/A
Active, not recruiting NCT04230928 - Giving a Low Carbohydrate Diet to Overcome Hypertension N/A
Recruiting NCT05286879 - Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Among Justice-involved Populations N/A
Completed NCT01415492 - Multiple Risk Behavior Intervention in Health Care Settings N/A